Filing Details
- Accession Number:
- 0001237899-11-000010
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-01-07 16:04:31
- Reporting Period:
- 2011-01-06
- Filing Date:
- 2011-01-07
- Accepted Time:
- 2011-01-07 16:04:31
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
872589 | Regeneron Pharmaceuticals Inc | REGN | Pharmaceutical Preparations (2834) | 133444607 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1013064 | Roy P Vagelos | 777 Old Saw Mill River Road Tarrytown NY 10591 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2011-01-06 | 21,043 | $34.04 | 110,512 | No | 4 | S | Direct | |
Common Stock | Disposition | 2011-01-04 | 6,311 | $0.00 | 183,808 | No | 5 | G | Indirect | by CLAT |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 5 | G | Indirect | by CLAT |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 2,156 | Indirect | By 401(k) Plan |
Common Stock | 125,000 | Indirect | by GRAT |
Common Stock | 235,000 | Indirect | by Spouse as Trustee |
Footnotes
- Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
- The reporting person sold 21,043 shares of Company stock on January 6, 2011 at prices ranging from $34.00 to $34.14. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 6, 2011 at each separate price.
- Gift of Common Stock to charitable organization.